In FDA’s continuing effort to increase the availability of serology – i.e. antibody – tests, we issued an emergency use authorization (EUA) to Abbott Laboratories Inc. for its SARS-CoV-2 IgG serology test. This is FDA’s eighth EUA for a serology test. https://t.co/PjWkgj2R2Qpic.twitter.com/u6henGBRNl